A detailed history of Stonehearth Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Stonehearth Capital Management, LLC holds 250 shares of LLY stock, worth $198,917. This represents 0.09% of its overall portfolio holdings.

Number of Shares
250
Previous 265 5.66%
Holding current value
$198,917
Previous $239,000 7.53%
% of portfolio
0.09%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$772.14 - $960.02 $11,582 - $14,400
-15 Reduced 5.66%
250 $221,000
Q1 2024

Apr 02, 2024

BUY
$592.2 - $792.28 $156,933 - $209,954
265 New
265 $206,000
Q4 2017

Jan 12, 2018

BUY
$81.94 - $87.89 $20,485 - $21,972
250
250 $21,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Stonehearth Capital Management, LLC Portfolio

Follow Stonehearth Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonehearth Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonehearth Capital Management, LLC with notifications on news.